How Long Has Ozempic Been Around? Timeline Guide

Ozempic first hit the market in the United States in December 2017 when the FDA approved it for managing type 2 diabetes. That means as of 2026, Ozempic has been around for about nine years. But the story of how it came to be — and how it became a household name for weight loss — goes back much further than that. This timeline guide covers the key dates, the science behind the drug, and how its use has changed over time.

What Is Ozempic and How Does It Work?

Ozempic is the brand name for a drug called semaglutide. It belongs to a class of medications known as GLP-1 receptor agonists. These drugs mimic a natural hormone in your body called glucagon-like peptide-1.

GLP-1 has several jobs. It tells your pancreas to release more insulin after you eat. It slows down how fast your stomach empties food. And it signals your brain that you are full. This combination lowers blood sugar and reduces appetite.

Ozempic is injected once a week. It was designed specifically for people with type 2 diabetes. But researchers quickly noticed that patients taking it were also losing significant amounts of weight. That observation led to further studies and eventually a separate approval for weight loss under the brand name Wegovy.

How Long Has Ozempic Been Around? A Complete Timeline

The active ingredient in Ozempic, semaglutide, was first developed by the Danish pharmaceutical company Novo Nordisk. Research on GLP-1 drugs started in the 1990s, but semaglutide itself was a newer, more stable version.

Here are the major milestones:

• 2012: Novo Nordisk begins clinical trials for semaglutide. Early studies focus on blood sugar control in people with type 2 diabetes.
• 2016: Large phase 3 trials, called the SUSTAIN program, show that semaglutide lowers blood sugar effectively and leads to weight loss as a side effect.
• December 2017: The FDA approves Ozempic for type 2 diabetes in adults. It launches in the US shortly after.
• 2019: Ozempic becomes available in more countries including Canada and parts of Europe. Prescriptions begin to climb.
• 2020: The FDA approves a higher-dose version of semaglutide specifically for chronic weight management. This is sold under the brand name Wegovy.
• 2021: Wegovy officially launches. Public interest in Ozempic skyrockets as people realize both drugs contain the same active ingredient.
• 2022-2023: Social media drives massive demand. Ozempic is prescribed off-label for weight loss. Shortages become common.
• 2024-2026: Novo Nordisk invests in increased production. Generic versions remain unavailable. New oral forms of semaglutide are in late-stage trials.

So the short answer is that Ozempic has been around since late 2017. But semaglutide, the molecule behind it, has been studied for over a decade before that.

What Does the Research on Ozempic Show?

Research on Ozempic is strong. The SUSTAIN trials included more than 8,000 patients and showed that semaglutide lowers A1C levels significantly better than many older diabetes drugs. Patients also lost an average of 8 to 14 pounds depending on the dose.

For weight loss specifically, the STEP trials tested a higher 2.4 mg dose of semaglutide. That study, published in the New England Journal of Medicine in 2021, found that participants lost an average of 15 percent of their body weight over 68 weeks. That is a large effect compared to most weight loss medications.

Current research suggests that semaglutide also reduces the risk of major cardiovascular events in people with type 2 diabetes and heart disease. The FDA added this benefit to the Ozempic label in 2020. This is not a small finding — it means the drug does more than just manage blood sugar.

One thing to be clear about: Ozempic has not been studied long-term beyond a few years. The longest trials run about two to three years. We do not have data on what happens if someone takes it for a decade. That is an honest gap in the evidence.

What Are the Side Effects and Risks?

Ozempic is effective, but it is not gentle. The most common side effects are gastrointestinal. Nausea, vomiting, diarrhea, and constipation affect a large number of people, especially when starting the drug or increasing the dose.

These side effects usually improve over time. But for some people they do not go away. Doctors typically start patients on a low dose and increase it slowly to reduce these issues.

More serious risks exist but are less common. They include pancreatitis, gallbladder disease, and a condition called gastroparesis where the stomach stops emptying properly. There is also a rare risk of thyroid tumors, which was seen in animal studies but has not been confirmed in humans.

As of 2026, the FDA continues to monitor reports of suicidal thoughts in people taking GLP-1 drugs. So far no clear link has been established, but it remains an area of active investigation.

Is Ozempic the Same as Wegovy?

This is one of the most confusing parts of the Ozempic story. Ozempic and Wegovy contain the exact same active ingredient: semaglutide. But they are not the same product.

Ozempic is approved for type 2 diabetes. It comes in doses up to 1 mg per week and sometimes 2 mg. Wegovy is approved for weight management. It uses a higher dose of 2.4 mg per week. The dosing schedule is also different when starting each drug.

Doctors sometimes prescribe Ozempic off-label for weight loss. This is legal but not FDA-approved. The main reason people do this is insurance coverage. Many plans cover Ozempic for diabetes but not Wegovy for weight loss.

The drug shortages that started in 2022 were driven largely by people without diabetes using Ozempic for weight loss. This created real problems for patients who rely on it for blood sugar control. The situation has improved but not fully resolved as of early 2026.

What to Avoid When Considering Ozempic

Do not buy Ozempic from online pharmacies that do not require a prescription. Counterfeit versions have been found. The FDA has issued warnings about fake injections that contain no active ingredient or the wrong substance entirely.

Do not assume Ozempic is a quick fix. Weight loss stops once you stop the drug. Studies show that most people regain weight within a year of quitting. This is not a failure of willpower — it is how the drug works. It suppresses appetite while you take it and stops working when you do not.

Do not take Ozempic if you have a personal or family history of medullary thyroid cancer or MEN2 syndrome. This is the one group where the thyroid tumor risk found in animals is considered relevant enough to be a strict contraindication.

Do not expect dramatic results in the first week. The drug builds up in your system over several weeks. Most people do not feel the full appetite suppression until they reach the maintenance dose, which can take one to two months.

Common Misconceptions About Ozempic

A common myth is that Ozempic is a new drug. It has been on the market since 2017, which is nearly a decade. Another myth is that it is a weight loss drug first. It was developed and approved for diabetes. The weight loss effect was discovered during diabetes trials.

Some people believe Ozempic works by speeding up metabolism. It does not. It works by reducing appetite and slowing stomach emptying. You eat less because your brain thinks you are full longer.

Another misconception is that everyone loses a lot of weight. In clinical trials, about 15 percent of people did not lose significant weight. The drug is not effective for everyone, and researchers do not fully understand why.